CS logo
small CS logo
Zhongshan Hospital, Fudan University

Shanghai, Shanghai, China
Hospital in Shanghai
180 Fenglin Rd, Xuhui District, Shanghai, 200031

About Zhongshan Hospital, Fudan University


Zhongshan Hospital, formerly Chung Shan Memorial Hospital, is a major teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shanghai Zhongshan Hospital
157
Fudan University
42
Hoffmann-La Roche
31
Boehringer Ingelheim
12
BeiGene
10
Beijing Friendship Hospital
9
Eli Lilly and Company
9
Jiangsu HengRui Medicine Co., Ltd.
9
Merck Sharp & Dohme LLC
9
Shanghai Gynecologic Oncology Group
9
Janssen Research & Development, LLC
8
Total Rows: 100

Clinical Trials at Zhongshan Hospital, Fudan University


During the past decade, Zhongshan Hospital, Fudan University conducted 471 clinical trials. In the 10-year time frame, 471 clinical trials started and 48 clinical trials were completed, i.e. on average, 10.2% percent of trials that started reached the finish line to date. In the past 5 years, 225 clinical trials started and 31 clinical trials were completed. i.e. 13.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years42423636555554545959646497975959553322332277141410104433Started TrialsCompleted Trails201520162017201820192020202120222023050100150
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis
2004-07-01
2004-12-31
Completed
150
A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
2004-07-01
2004-12-01
Completed
168
A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
2003-06-01
2004-03-01
Completed
200
Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
2006-01-01
2006-12-01
Completed
61
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
2007-01-01
2007-11-01
Completed
698
A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong
2005-09-01
2007-12-01
Completed
600
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
2007-11-01
2012-07-01
Unknown status
290
Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
2004-09-01
2008-07-01
Unknown status
400

Rows per page:

1–100 of 604

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Zhongshan Hospital, Fudan University" #1 sponsor was "Shanghai Zhongshan Hospital" with 157 trials, followed by "Fudan University" with 42 trials sponsored, "Hoffmann-La Roche" with 31 trials sponsored, "Boehringer Ingelheim" with 12 trials sponsored and "BeiGene" with 12 trials sponsored. Other sponsors include 347 different institutions and companies that sponsored additional 192 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan Hospital, Fudan University" #1 collaborator was "Shanghai Zhongshan Hospital" with 46 trials as a collaborator, "Fudan University" with 27 trials as a collaborator, "Ruijin Hospital" with 19 trials as a collaborator, "RenJi Hospital" with 16 trials as a collaborator and "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 15 trials as a collaborator. Other collaborators include 622 different institutions and companies that were collaborators in the rest 320 trials.
Created with Highcharts 11.1.0Top Leading SponsorsShanghai ZhongshanHospital: 157Shanghai ZhongshanHospital: 157Fudan University: 42Fudan University: 42Hoffmann-La Roche: 31Hoffmann-La Roche: 31Boehringer Ingelheim: 12Boehringer Ingelheim: 12BeiGene: 10BeiGene: 10Beijing Friendship Hospital: 9Beijing Friendship Hospital: 9Eli Lilly and Company: 9Eli Lilly and Company: 9Jiangsu HengRuiMedicine Co., Ltd.: 9Jiangsu HengRuiMedicine Co., Ltd.: 9Merck Sharp & Dohme LLC: 9Merck Sharp & Dohme LLC: 9Shanghai GynecologicOncology Group: 9Shanghai GynecologicOncology Group: 9

Created with Highcharts 11.1.0Top CollaboratorsShanghai ZhongshanHospital: 46Shanghai ZhongshanHospital: 46Fudan University: 27Fudan University: 27Ruijin Hospital: 19Ruijin Hospital: 19RenJi Hospital: 16RenJi Hospital: 16Shanghai GeneralHospital, Shanghai JiaoTong University Schoolof Medicine: 15Shanghai GeneralHospital, Shanghai JiaoTong University Schoolof Medicine: 15Shanghai Public HealthClinical Center: 11Shanghai Public HealthClinical Center: 11Huashan Hospital: 10Huashan Hospital: 10Tongji Hospital: 10Tongji Hospital: 10Changhai Hospital: 9Changhai Hospital: 9West China Hospital: 9West China Hospital: 9

Clinical Trials Conditions at Zhongshan Hospital, Fudan University


According to Clinical.Site data, the most researched conditions in "Zhongshan Hospital, Fudan University" are "Hepatocellular Carcinoma" (35 trials), "Gastric Cancer" (19 trials), "Coronary Artery Disease" (18 trials), "Colorectal Cancer" (15 trials) and "Colorectal Neoplasms" (10 trials). Many other conditions were trialed in "Zhongshan Hospital, Fudan University" in a lesser frequency.

Clinical Trials Intervention Types at Zhongshan Hospital, Fudan University


Most popular intervention types in "Zhongshan Hospital, Fudan University" are "Drug" (359 trials), "Device" (92 trials), "Procedure" (84 trials), "Other" (49 trials) and "Biological" (22 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (61 trials), "Atezolizumab" (21 trials), "Cisplatin" (17 trials), "placebo" (11 trials) and "Tislelizumab" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Zhongshan Hospital, Fudan University


The vast majority of trials in "Zhongshan Hospital, Fudan University" are 573 trials for "All" genders, 17 trials for "Female" genders and 14 trials for "Male" genders.

Clinical Trials Status at Zhongshan Hospital, Fudan University


Currently, there are 265 active trials in "Zhongshan Hospital, Fudan University". 21 are not yet recruiting, 177 are recruiting, 62 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 158 completed trials in Zhongshan Hospital, Fudan University, 2 suspended trials, and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Zhongshan Hospital, Fudan University, 46 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 169 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 66 trials, and there were also 129 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 169Phase 3: 169Not Applicable: 129Not Applicable: 129Phase 2: 115Phase 2: 115Phase 4: 66Phase 4: 66Phase 1: 46Phase 1: 46Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusRecruiting: 177Recruiting: 177Unknown status: 162Unknown status: 162Completed: 158Completed: 158Active, not recruiting: 62Active, not recruiting: 62Not yet recruiting: 21Not yet recruiting: 21Terminated: 14Terminated: 14Enrolling by invitation: 5Enrolling by invitation: 5Withdrawn: 3Withdrawn: 3Suspended: 2Suspended: 2